Abstract:Abstract DEP-Domain Containing mTOR-Interacting Protein (DEPTOR) is frequently overexpressed in multiple myelomas and required for cell survival. However, its implications in other hematological malignancies and the precise mechanisms of regulation remain largely undefined. Here, we systematically analyzed DEPTOR expression in human acute lymphoblastic leukemia (ALL), a hematological malignancy accounting for 80% of pediatric leukemia. Whereas substantially inhibited in B-ALLs, unexpectedly, expression of DEPTOR is significantly elevated in a subset of T-ALLs where NOTCH1 is aberrantly activated. Mechanistically, we show DEPTOR expression is dependent on NOTCH signaling in T-ALL cell lines and primary specimens, and demonstrate NOTCH1 directly binds to and activates human DEPTOR promoter. DEPTOR depletion in T-ALL cells abolishes proliferation, attenuates glucose metabolism, enhances apoptosis and sensitizes resistant cells to γ-secretase inhibitor or dexamethasone treatments. Conversely, ectopically expressed DEPTOR promotes proliferation and aerobic glycolysis, and confers dexamethasone resistance. DEPTOR functions through AKT-dependent mechanisms to sustain cell proliferation and drug resistance, while the AKT-independent roles of DEPTOR appear to promote glucose metabolism. We therefore define a novel mechanism that, in addition to the previously reported HES1/PTEN-mediated regulation of AKT, NOTCH1 alternatively activates AKT through inducing the downstream target gene DEPTOR. Our findings thereby highlight DEPTOR as a critical mediator in leukemogenesis and suggest DEPTOR expression may serve as a potential biomarker predicting glucocorticoid resistance and targeting DEPTOR may achieve better therapeutic benefits. Citation Format: Yufeng Hu, Hexiu Su, Qi Ye, Zhaojing Wang, Liang Huang, Qian Wang, Shuangyou Liu, Suning Chen, Jianfeng Zhou, Peng Li, Guoliang Qing, Hudan Liu. DEPTOR is a direct NOTCH1 target that regulates proliferation, metabolism and glucocorticoid resistance in T cell leukemia. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2095. doi:10.1158/1538-7445.AM2015-2095

Deptor Has Growth Suppression Activity Against Pancreatic Cancer Cells

DEPTOR is a Direct P53 Target That Suppresses Cell Growth and Chemosensitivity

DEPTOR Stabilizes ErbB2 to Promote the Proliferation and Survival of ErbB2-positive Breast Cancer Cells.

DEPTOR Inhibits Lung Tumorigenesis by Inactivating the EGFR-mTOR Signals.

DEPTOR is an in Vivo Tumor Suppressor That Inhibits Prostate Tumorigenesis Via the Inactivation of Mtorc1/2 Signals

DEPTOR As a Novel Prognostic Marker Inhibits the Proliferation Via Deactivating Mtor Signaling Pathway in Gastric Cancer Cells

DEPTOR Inhibits Cell Proliferation and Confers Sensitivity to Dopamine Agonist in Pituitary Adenoma.

DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma

Downregulation of DEPTOR Inhibits the Proliferation, Migration, and Survival of Osteosarcoma Through PI3K/Akt/mTOR Pathway

OTUB1 protein suppresses mTOR complex 1 (mTORC1) activity by deubiquitinating the mTORC1 inhibitor DEPTOR

Reciprocal Negative Regulation Between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma

Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysis.

A Subset of Metastatic Pancreatic Ductal Adenocarcinomas Depends Quantitatively on Oncogenic Kras/Mek/Erk-Induced Hyperactive Mtor Signalling

Expression of DEK in Pancreatic Cancer and Its Correlation with Clinicopathological Features and Prognosis

DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagy.

Abstract 4160: DEPTOR, an mTOR inhibitor, is a novel substrate of SCFαTrCP E3 ubiquitin ligase upon S6K1/RSK1 phosphorylation and regulates survival and autophagy

Abstract 2095: DEPTOR is a Direct NOTCH1 Target That Regulates Proliferation, Metabolism and Glucocorticoid Resistance in T Cell Leukemia

Co-treatment with Everolimus, an Mtor-Specific Antagonist, or Downregulation of ELK1 Enhances the Sensitivity of Pancreatic Cancer Cells to Genistein

Expression and Purification of Deptor and Its Interaction with Mtor-Trd2

Protein Tyrosine Phosphatase Nonreceptor Type 2 Exerts Antimetastatic Functions in Pancreatic Ductal Adenocarcinoma.

Expression of Key Mtor Pathway Components in Pancreatic Ductal Adenocarcinoma: A Multicenter Study for Clinicopathologic and Prognostic Significance.